Sardano Michael
PRESIDENT AND GENERAL COUNSEL
Sardano Michael has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Dec 16, 2025.
On the most recent filing, Sardano Michael is listed as PRESIDENT AND GENERAL COUNSEL at Sensus Healthcare, Inc. Inside the rolling window, Sardano Michael reported 2 open-market purchases totaling $13K in SRTS and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,234 SRTS shares on Nov 11, 2025, worth $10K.
Companies traded
Other insiders at SRTS
Insider Buying
$13K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sardano Michael made?
Sardano Michael has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Sardano Michael trade?
Sardano Michael has filed SEC Form 4 disclosures for 1 company, including SRTS.
When was Sardano Michael's most recent SEC Form 4 filing?
Sardano Michael's most recent SEC Form 4 filing on Tracefour is dated Dec 16, 2025.
What is Sardano Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sardano Michael is listed as PRESIDENT AND GENERAL COUNSEL.
What is Sardano Michael's total buy and sell value in the current window?
Inside the rolling retention window, Sardano Michael bought $13K and sold $0 based on SEC Form 4 filings.
What was Sardano Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,234 SRTS shares on 2025-11-11, worth $10K, per SEC Form 4 filings.